美国商会：2023年创新药物可及性研究报告（英文版）（30页）.pdf

1、Patient Access Report2 2Table of ContentsExecutive Summary.4Introduction and Briefing Document Objective.7Measuring Biopharmaceutical Market Access Barriers.10Fewer Innovative Medicines and Longer Wait Times.16Conclusion.24Appendix.253The U.S.Chamber of Commerces Global Innovation Policy Center()is

2、working around the world to champion intellectual property rights as vital to creating jobs,saving lives,advancing global economic growth,and generating breakthrough solutions to global challenges.The U.S.Chamber of Commerce is the worlds largest business federation representing the interests of mor

3、e than 3 million businesses of all sizes,sectors,and regions,as well as state and local chambers and industry associations.This report was conducted by Pugatch Consilum,(www.pugatch-)a boutique consultancy that provides evidence-based research,analysis,and intelligence on the fastest growing sectors

4、 of the knowledge economy.Authors of this report are Meir Pugatch and David Torstensson.Professor Meir Pugatch,Managing Director and Founder|Prof.Pugatch is the Managing Director of Pugatch Consilium a boutique consultancy that provides evidence-based research,analysis and intelligence on the fastes

5、t growing sectors of the knowledge economy.He is an IPKM Professor of Valorisation,Entrepreneurship and Management at the University of Maastricht in the Netherlands;as well as a Professor at the School of Public Health,University of Haifa in Israel,in which he acts as the Chair of the Health Manage

6、ment Division since 2019.Prof.Pugatch specializes in innovation strategies,organizational entrepreneurship,intellectual property management,pharmacoeconomics,pricing and reimbursement,and the management of public health systems.He is the author and editor of an extensive number of publications and s